The country’s sharp right turn in the 2024 election — even in pockets of liberal Boston – could provide a pathway for a potential Ed Flynn challenge to Mayor Michelle Wu in 2025. Donald Trump’s gains ...
Boston Scientific (NYSE: BSX) is scheduled to report its Q3 2024 results on Wednesday, October 23. We expect the company to report revenues and earnings slightly below the consensus estimates.
Boston Scientific Corporation (BSX), a Massachusetts-based company with a market cap of $123.1 billion, is a leader in the medical devices sector. Specializing in interventional medical ...
Credit: Sundry Photography via Shutterstock. Boston Scientific has resumed enrolment for its AVANT GUARD clinical trial, after it was paused in October 2024to “assess a few unanticipated observations” ...
Boston Scientific (NYSE: BSX) + today reported third-quarter results that came in ahead of the consensus forecast, raising its 2024 guidance again. The company’s CEO also said on its third ...